TNXP | Tonix Pharmaceuticals Holding Corp
Category: Consumer goods
Quick infos Headquarters: United States of America Trade prices Volume: Market Cap: 110.66M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: May 16, 2022
Earnings History Date EPS / Forecast Revenue / Forecast May 16, 2022 March 14, 2022 -0.07 / -0.06- / -November 8, 2021 -0.05 / -0.07- / -August 16, 2021 - / -0.065- / -May 17, 2021 - / -0.05- / -view more
Historical Data Date Price Open High Low Vol Change ER Mar 18, 2022 0.2400 0.2500 0.2627
0.2367
38.66M -5.62% Mar 17, 2022 0.2543 0.2217 0.2594
0.2211
20.98M 9.09% Mar 16, 2022 0.2331 0.2130 0.2336
0.2100
25.48M 9.64% Mar 15, 2022 0.2126 0.2093 0.2150
0.2000
13.72M 1.24% Mar 14, 2022 0.2100 0.2298 0.2298
0.2060
16.51M -5.83% Mar 11, 2022 0.2230 0.2239 0.2370
0.2164
16.54M -0.45% Mar 10, 2022 0.2240 0.2211 0.2300
0.2151
19.71M -2.9% Mar 9, 2022 0.2307 0.2375 0.2399
0.2110
38.55M 2.31% Mar 8, 2022 0.2255 0.1917 0.2336
0.1734
54.41M 12.69% Mar 7, 2022 0.2001 0.2177 0.2200
0.1969
38.22M -3.33% view more
More profiles and info about the company News
Tonix Pharmaceuticals Announces Clearance of IND for TNX-102 SL for Treatment of Alcohol Use Disorder finance.yahoo.com Aug 11, 2020 9:00 am
The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon finance.yahoo.com Aug 11, 2020 7:22 am
Tonix Pharmaceuticals Announces Publication of Paper on Triple Reuptake Inhibitor TNX-1600 (formerly D-578) in the European Journal of Pharmacology finance.yahoo.com Aug 11, 2020 7:00 am
Tonix Pharmaceuticals Announces Closing of $9.0 Million Public Offering finance.yahoo.com Aug 11, 2020 7:00 am Tonix Pharmaceuticals EPS misses by $0.02 seekingalpha.com Aug 10, 2020 8:51 pm
Tonix Pharmaceuticals Announces Initiation of the Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia finance.yahoo.com Aug 10, 2020 8:00 am
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns finance.yahoo.com Aug 10, 2020 7:32 am
TNXP: TNX-102 SL P3 PTSD Trial Interim Readout in 1Q20; P3 Trial in Fibromyalgia Underway finance.yahoo.com Aug 10, 2020 7:20 am Tonix Pharma on go with study of TNX-102 SL in alcohol use disorder seekingalpha.com Aug 6, 2020 9:43 pm Tonix Pharma meets Nasdaq minimum bid price requirement seekingalpha.com Aug 4, 2020 11:17 pm
Registration for Sidoti's 2020 Fall Virtual Investor Conference is Open Now finance.yahoo.com Jul 31, 2020 12:38 pm
Tonix Pharmaceuticals Announces that Results from a Preclinical Study of TNX-1900 Will be Presented in a Poster at the AAN Sports Concussion Virtual Conference finance.yahoo.com Jul 27, 2020 7:00 am Three poorly-rated stocks Robinhood investors are buying, and a suggestion why seekingalpha.com Jul 23, 2020 3:23 am
Tonix Pharmaceuticals Announces Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics finance.yahoo.com Jul 16, 2020 9:00 am
Tonix Pharmaceuticals Announces Research Collaboration with Southern Research to Develop a Potential Vaccine to Protect Against New Coronavirus Disease 2019 (COVID-19) Based on Horsepox Virus (TNX-1800) finance.yahoo.com Aug 11, 2020 7:00 am
Tonix Pharmaceuticals Announces that Results from a Preclinical Study of TNX-1900 are Posted at the AAN Sports Concussion Virtual Conference finance.yahoo.com Aug 11, 2020 7:00 am
Tonix Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights finance.yahoo.com Aug 10, 2020 8:45 am
Tonix Pharmaceuticals Announces Issuance of U.S. Patent for Crystalline Tianeptine Oxalate Salt, the Active Ingredient of TNX-601 finance.yahoo.com Aug 10, 2020 7:00 am
Tonix Pharmaceuticals to Participate in Two June Virtual Investor Conferences finance.yahoo.com Aug 10, 2020 7:00 am
Tonix Pharmaceuticals and Southern Research Announce Expansion of COVID-19 Vaccine Collaboration finance.yahoo.com Aug 10, 2020 7:00 am Talk about Tonix Pharmaceuticals Holding Corp below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!